Apogee Therapeutics, Inc. Quarterly Assets in USD from Q4 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Apogee Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2022 to Q2 2024.
Apogee Therapeutics, Inc. Assets for the quarter ending June 30, 2024 was $801M, a 513% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$801M	+$670M	+513%	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$824M			Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$401M	+$249M	+164%	Dec 31, 2023	10-Q	2024-08-12
Q3 2023	$426M			Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$131M			Jun 30, 2023	10-Q	2023-08-28
Q4 2022	$152M			Dec 31, 2022	10-K	2024-03-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.